Xcelience (Acquired by Capsugel) Revenue and Competitors

Orlando, FL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Xcelience (Acquired by Capsugel)'s estimated annual revenue is currently $6.6M per year.(i)
  • Xcelience (Acquired by Capsugel)'s estimated revenue per employee is $201,000

Employee Data

  • Xcelience (Acquired by Capsugel) has 33 Employees.(i)
  • Xcelience (Acquired by Capsugel) grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.5M132N/AN/AN/A
#2
$10.1M5014%N/AN/A
#3
$282.6M1406N/AN/AN/A
#4
$13.9M6944%N/AN/A
#5
$11.3M564%N/AN/A
#6
$11.5M57-7%N/AN/A
#7
$211.7M10724%N/AN/A
#8
$24.1M1205%N/AN/A
#9
$7.8M39-2%N/AN/A
#10
$12.9M64-2%N/AN/A
Add Company

What Is Xcelience (Acquired by Capsugel)?

Xcelience is now part of Capsugel. Capsugel designs, develops and manufactures a wide range of innovative dosage forms for the biopharmaceutical and consumer health and nutrition industries. Our unique combination of science, engineering, formulation and capsule expertise enables our customers to optimize the bioavailability, targeted delivery and overall performance of their products. We create novel, high-quality and customized solutions that align with our customers’ evolving needs and benefit patients and consumers. We continue to build on our decades-long track record of ingenuity, credibility and flexibility to drive added value creation for our customers. Our proprietary and patent-protected technologies, our extensive formulation know-how, our unrivaled expertise in capsule polymer science, and our product and process design capabilities help our customers meet their target product profiles and commercial objectives, while allowing rapid design and development across a wide range of dosage forms.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$6.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.1M33-15%N/A
#2
$8.1M333%N/A
#3
$7.1M33-6%N/A
#4
$7.5M3310%N/A
#5
$8.7M3310%N/A